Published in J Clin Microbiol on January 01, 2003
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc (2008) 3.46
Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother (2006) 2.18
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol (2007) 1.99
Fungal biofilm resistance. Int J Microbiol (2012) 1.73
Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi. PLoS One (2007) 1.70
Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother (2005) 1.61
Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun (2007) 1.59
Characterization of mucosal Candida albicans biofilms. PLoS One (2009) 1.51
Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method. Antimicrob Agents Chemother (2005) 1.42
Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother (2005) 1.33
Recent insights into Candida albicans biofilm resistance mechanisms. Curr Genet (2013) 1.20
Optimizing a Candida biofilm microtiter plate model for measurement of antifungal susceptibility by tetrazolium salt assay. J Clin Microbiol (2011) 1.18
Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol (2007) 1.17
Invasive phenotype of Candida albicans affects the host proinflammatory response to infection. Infect Immun (2005) 1.09
Comparative analysis of Candida biofilm quantitation assays. Med Mycol (2011) 1.07
Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol (2005) 0.99
A 96 well microtiter plate-based method for monitoring formation and antifungal susceptibility testing of Candida albicans biofilms. J Vis Exp (2010) 0.98
A combination of assays reveals biomass differences in biofilms formed by Escherichia coli mutants. Lett Appl Microbiol (2009) 0.95
A quantitative real-time RT-PCR assay for mature C. albicans biofilms. BMC Microbiol (2011) 0.93
Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol (2009) 0.91
Application of a high throughput Alamar blue biofilm susceptibility assay to Staphylococcus aureus biofilms. Ann Clin Microbiol Antimicrob (2009) 0.90
In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans. Antimicrob Agents Chemother (2009) 0.90
Micafungin activity against Candida albicans with diverse azole resistance phenotypes. J Antimicrob Chemother (2008) 0.90
In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol (2010) 0.86
Hydroxyethyl disulfide as an efficient metabolic assay for cell viability in vitro. Toxicol In Vitro (2012) 0.84
Farnesol in combination with N-acetylcysteine against Staphylococcus epidermidis planktonic and biofilm cells. Braz J Microbiol (2012) 0.83
In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. Antimicrob Agents Chemother (2012) 0.83
Effect of marine polyunsaturated fatty acids on biofilm formation of Candida albicans and Candida dubliniensis. Mar Drugs (2010) 0.80
XTT assay of ex vivo saliva biofilms to test antimicrobial influences. GMS Krankenhhyg Interdiszip (2012) 0.80
Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrob Agents Chemother (2014) 0.80
Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother (2014) 0.79
Development of a 96-well catheter-based microdilution method to test antifungal susceptibility of Candida biofilms. J Antimicrob Chemother (2011) 0.77
Evaluation of caries-associated virulence of biofilms from Candida albicans isolated from saliva of pediatric patients with sickle-cell anemia. J Appl Oral Sci (2015) 0.77
The role of Mss11 in Candida albicans biofilm formation. Mol Genet Genomics (2014) 0.76
Activity of potent and selective host defense peptide mimetics in mouse models of oral candidiasis. Antimicrob Agents Chemother (2014) 0.76
Glutamine deprivation plus BPTES alters etoposide- and cisplatin-induced apoptosis in triple negative breast cancer cells. Oncotarget (2016) 0.75
Comparative analysis of quantitative methodologies for Vibrionaceae biofilms. Folia Microbiol (Praha) (2016) 0.75
ILK-PI3K/AKT pathway participates in cutaneous wound contraction by regulating fibroblast migration and differentiation to myofibroblast. Lab Invest (2016) 0.75
Neural Cell Chip Based Electrochemical Detection of Nanotoxicity. Nanomaterials (Basel) (2015) 0.75
Inhibitory Effect of Alpha-Mangostin on Adhesion of Candida albicans to Denture Acrylic. Open Dent J (2015) 0.75
Monitoring the metabolic state of fungal hyphae and the presence of melanin by nonlinear spectral imaging. Appl Environ Microbiol (2013) 0.75
The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia. Antibiotics (Basel) (2014) 0.75
A Protocol For Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, ECM and Human White Cell Impenetrability of Candida albicans Biofilms. Antimicrob Agents Chemother (2017) 0.75
Synergistic reduction of toluylene blue induced by acetaldehyde and menadione in yeast cell suspension: Application to determination of yeast cell activity. Biochem Biophys Rep (2017) 0.75
Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods (1983) 114.35
Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol (2001) 6.98
An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J Immunol Methods (1991) 4.55
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52
Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun (1994) 4.15
A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis (1985) 3.58
A simplified new assay for assessment of fungal cell damage with the tetrazolium dye, (2,3)-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanil ide (XTT). J Infect Dis (1995) 3.57
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res (2001) 3.57
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun (2002) 2.94
Tetrazolium salts and formazans. Prog Histochem Cytochem (1976) 2.11
Adhesion of different Candida spp. to plastic: XTT formazan determinations. J Med Vet Mycol (1997) 1.13
Lymphocyte proliferation response during Eimeria tenella infection assessed by a new, reliable, nonradioactive colorimetric assay. Avian Dis (2002) 1.07
Binding of Candida albicans to immobilized amino acids and bovine serum albumin. Infect Immun (1998) 1.03
Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol (2001) 6.98
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol (2000) 6.33
Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother (2002) 4.52
Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev (2001) 4.49
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res (2001) 3.57
Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis (1996) 3.52
Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol (2001) 3.02
Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother (1998) 3.00
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol (2008) 2.95
Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun (2002) 2.94
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints. J Clin Microbiol (2006) 2.86
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun (1995) 2.75
Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis (2006) 2.17
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J Clin Microbiol (1998) 1.89
Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem (1998) 1.84
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother (1993) 1.80
Adenovirus-mediated wild-type p53 tumor suppressor gene therapy induces apoptosis and suppresses growth of human pancreatic cancer [seecomments]. Ann Surg Oncol (1998) 1.78
Effects of antineoplastic agents on growth, morphology and metabolism of Torulopsis glabrata. Mycopathologia (1986) 1.77
In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity. Infect Immun (2000) 1.73
Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol (2000) 1.68
Cloning and expression of a novel human glutaredoxin (Grx2) with mitochondrial and nuclear isoforms. J Biol Chem (2001) 1.63
In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother (1999) 1.63
Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol (1999) 1.58
Validation of IMNCI algorithm for young infants (0-2 months) in India. Indian Pediatr (2011) 1.58
New investigational antifungal agents for treating invasive fungal infections. Expert Opin Investig Drugs (2000) 1.55
Mechanism of fluconazole resistance in Candida krusei. Antimicrob Agents Chemother (1998) 1.52
Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res (2005) 1.50
Multisite reproducibility of MIC results by the Sensititre YeastOne colorimetric antifungal susceptibility panel. Diagn Microbiol Infect Dis (1998) 1.46
An evaluation of the in vitro activity of terbinafine. Med Mycol (2000) 1.42
Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun (1996) 1.39
Idiopathic pulmonary hemosiderosis. Indian J Pediatr (2000) 1.39
Therapeutic uses of methyl prednisolone. Indian Pediatr (1995) 1.38
Ceftibuten. Indian Pediatr (1999) 1.38
Double blind randomized comparative evaluation of nimesulide and paracetamol as antipyretics. Indian Pediatr (1998) 1.37
Indoor mold, toxigenic fungi, and Stachybotrys chartarum: infectious disease perspective. Clin Microbiol Rev (2003) 1.36
Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials. Curr Cancer Drug Targets (2011) 1.33
Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect Immun (1995) 1.31
Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage. Antimicrob Agents Chemother (1995) 1.24
Cerebral symptoms with P. vivax malaria. Indian Pediatr (1992) 1.24
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models. Antimicrob Agents Chemother (1997) 1.24
Gemcitabine-induced programmed cell death (apoptosis) of human pancreatic carcinoma is determined by Bcl-2 content. Ann Surg Oncol (1999) 1.23
An epidemic of dengue hemorrhagic fever and dengue shock syndrome in children in Delhi. Indian Pediatr (1998) 1.23
Estrogen mercapturic acids in the adult male rat. Steroids (1973) 1.23
Green synthesis of highly stabilized nanocrystalline silver particles by a non-pathogenic and agriculturally important fungus T. asperellum. Nanotechnology (2008) 1.20
Experimental evidence for the role of lipids in adherence of Candida spp. to human buccal epithelial cells. Infect Immun (1986) 1.19
Interferon-gamma protects endothelial cells from damage by Candida albicans. J Infect Dis (1993) 1.19
Mechanisms by which Candida albicans induces endothelial cell prostaglandin synthesis. Infect Immun (1994) 1.17
Endophthalmitis in the western Sydney region: a case-control study. Clin Experiment Ophthalmol (2001) 1.17
Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology (2001) 1.16
Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biol Chem (1997) 1.15
Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem Biophys Res Commun (1999) 1.13
Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J Clin Microbiol (2008) 1.13
Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values. Diagn Microbiol Infect Dis (2012) 1.11
Cloning and characterization of CAD1/AAF1, a gene from Candida albicans that induces adherence to endothelial cells after expression in Saccharomyces cerevisiae. Infect Immun (1998) 1.10
Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. J Clin Microbiol (1998) 1.08
Crude oil and hydrocarbon-degrading strains of Rhodococcus rhodochrous isolated from soil and marine environments in Kuwait. Environ Pollut (1990) 1.06
Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med (1997) 1.05
In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother (2009) 1.05
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail. Mycoses (1999) 1.05
MSI-99, a magainin analogue, imparts enhanced disease resistance in transgenic tobacco and banana. Planta (2002) 1.04
Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim Biophys Acta (1995) 1.04
Evaluation of antipyretic potential of Nelumbo nucifera stalk extract. Phytother Res (2000) 1.04
Biological function of gramicidin: studies on gramicidin-negative mutants. Proc Natl Acad Sci U S A (1977) 1.04
Gamma interferon protects endothelial cells from damage by Candida albicans by inhibiting endothelial cell phagocytosis. Infect Immun (1996) 1.03
Antifungal activity of miconazole against recent Candida strains. Mycoses (2009) 1.02
Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci U S A (1994) 1.01
Evaluation of hepatoprotective activity of Cassia fistula leaf extract. J Ethnopharmacol (1999) 1.01
Apoptosis and the response to anticancer therapy. Curr Opin Oncol (2001) 1.00
Fatal pulmonary infection caused by Mycobacterium smegmetis in an infant. Indian J Pediatr (2000) 1.00
Wound healing activity of Leucas lavandulaefolia Rees. J Ethnopharmacol (1997) 0.99
Role of S gene of bacteriophage lambda in host lysis. Biochem Biophys Res Commun (1976) 0.99
Macroscopic dynamics near the isotropic-smectic-A phase transition. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.98
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit. Clin Microbiol Infect (2009) 0.97
Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology (1997) 0.97
Fluconazole and platelet microbicidal protein inhibit Candida adherence to platelets in vitro. Antimicrob Agents Chemother (1994) 0.96
Caspase-dependent apoptosis induced by telomere cleavage and TRF2 loss. Neoplasia (2001) 0.96
Incidence and susceptibility of yeasts isolated from cancer patients in Kuwait. Mykosen (1985) 0.96
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol (1996) 0.96
Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs. J Eur Acad Dermatol Venereol (2011) 0.96
Agar-based disk diffusion assay for susceptibility testing of dermatophytes. J Clin Microbiol (2010) 0.95
The exciting future of antifungal therapy. Eur J Clin Microbiol Infect Dis (2000) 0.95
Comparison of the effect of linear gramicidin analogues on bacterial sporulation, membrane permeability, and ribonucleic acid polymerase. Biochemistry (1979) 0.95
Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol (1999) 0.94
Successful treatment of Candida albicans osteomyelitis of the spine with fluconazole and surgical debridement: case report. J Chemother (2002) 0.94
In vitro cytotoxicity and antitumour properties of Hypericum mysorense and Hypericum patulum. Phytother Res (2003) 0.93